glp-1 agonist review Glucagon‐like peptide agonists: A prospective - Mariam - 2024 - Endocrinology, Diabetes & Metabolism Current Insights, Advantages and Challenges

We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.

And better decisions support long-term health

Ever wonder what happens when you stop taking GLP-1 medications like Wegovy or Zepbound for weight loss

Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH